Method of inhibiting angiogenesis by using ephrin B2

Details for Australian Patent Application No. 2006300222 (hide)

Owner Aqumen Biopharmaceuticals K.K. Kyushu University

Inventors Sasa, Yukio; Fujisawa, Kimihiko; Kagimoto, Tadahisa; Ishibashi, Tatsuro

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-A-2006300222

PCT Pub. Number WO2007/043629

Priority 2005-292406 05.10.05 JP

Filing date 5 October 2006

Wipo publication date 19 April 2007

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/14 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/00 (2006.01) Mutation or genetic engineering

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/043629 Priority application(s): WO2007/043629

22 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006300234-Agents for suppressing damage to transplanted islets after islets transplantation

2006300215-Novel dihydropseudoerythromycin derivatives